“To predict what’s coming for patents in China, one can review regulations and guidelines, track court cases, and talk with examiners, but the upcoming presidential election introduces considerable ...

Lower prices reflect growing competition in the market for glucagon-like peptide-1 weight-loss drugs. The patent in China for semaglutide, marketed as Wegovy, will expire next March 20, and domestic ...

China dominates the global race in generative artificial intelligence patents, filing more than 38,000 patents from 2014 to 2023, a new United Nations report on Thursday showed. That's six times more ...

China has met the intellectual property targets set in its 14th Five-Year Plan (2021-25), with improvements in innovation ...

Novo Nordisk has been handed a crucial legal win by China's Supreme Court, which has upheld the company's patent protection ...

The introduction of absolute novelty and a system requiring companies in China to seek permission from SIPO before filing abroad are among patent amendments approved in China The introduction of ...

Novo Nordisk A/S launches oral Wegovy in the U.S. with aggressive pricing as China patent expiry looms. Click for this ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Chunguang Hu of China PAT explains why his ‘insider’ experience as a patent examiner benefits clients and why he wants to ...

Analysis of global patents data held by GlobalData shows that China is emerging as the largest source for patents – applied for and granted – in the area of electric vehicle powertrain batteries. In ...